CClinicalTrials.gg
Not yet recruitingNCT06979063Updated May 18, 2025

Health Education for Women With Suspeced Infertility Waiting for Specialized Care

An interventional study of Remote Infertility Education and Counseling and Standard Care Arm in Infertility, Health Education and Telemedicine, sponsored by Hospital de Clinicas de Porto Alegre. Not yet recruiting at 1 site in Brazil. Open to female participants aged 18 Years to 34 Years. Per ClinicalTrials.gov, last updated 2025-05-18.

Sponsored by Hospital de Clinicas de Porto Alegre · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
206
Allocation
Randomized
Ages
18 Years to 34 Years
Sex
Female
01

Study summary

Introduction: Infertility is defined as a couple's inability to achieve pregnancy after 12 months or more of regular unprotected intercourse. In Brazil, it affects around eight million people. While health services provide resources for contraception, little attention is given to supporting conception and preserving fertility.

Objective: To evaluate the effectiveness of a remote educational and counseling intervention on infertility.

Method: Open-label randomized clinical trial. Couples referred for infertility will be identified in the electronic referral system. For inclusion, the woman of the couple must be 34 years old or less, no previous in-vitro fertilization attempts, and have access to telephone or internet. The control group will follow standard care, awaiting in-person consultation. The intervention group will also wait for in-person evaluation but receive additional education and counseling via video call.

The primary outcome is the proportion of correct referrals according to local protocols. A total of 206 participants will be included to detect a difference between success rates of 50% and 30%, with 80% power and a 5% significance level.

02

Conditions studied

  • Infertility
  • Health Education
  • Telemedicine
  • Telehealth

Browse trials for

03

In context

Infertility

2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.

This study's planned enrollment of 206 is above the median of 120 across 1,698 interventional studies indexed under Infertility.

Browse Infertility studies →

Lead sponsor

Hospital de Clinicas de Porto Alegre is the lead sponsor of 450 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 34 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Individuals referred to specialized infertility care in Porto Alegre.
  • Age up to 33 years and 11 months.

Exclusion criteria

Exclusion Criteria:

  • Lack of access to the internet or telephone.
  • Prior specialized infertility treatment in the private healthcare system.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
206 participants (estimated)

Study arms

  • Active comparator
    Standard care

    Wait for specialized infertility consultation, following the usual health system process.

    Other: Standard Care Arm

  • Experimental
    intervention group

    Remote counseling and education about infertility and healthcare system navigation.

    Other: Remote Infertility Education and Counseling · Other: Standard Care Arm

Interventions

  • OtherRemote Infertility Education and Counseling

    Patients receive video call counseling covering infertility investigation, non-pharmacological fertility enhancement strategies, and healthcare navigation guidance. Health professionals review patient records and request missing infertility-related exams according to local protocol. Additional follow-ups occur approximately every 30 days to assist with pending investigations. If significant findings arise, patients will receive an explanation and assistance in scheduling primary care consultations.

  • OtherStandard Care Arm

    Referrals from patients will be avaluated following local protocols in the electronic referral system. Incomplete data will be requested through this system. There will be no direct contact with patients.

06

What researchers measure

Primary outcomes

  1. Correct referral

    Proportion of participants correctly referred to specialized care according to local protocols.

    Time frame: Six months after randomization

Secondary outcomes

  1. Proportion of patients with conception plan achieved.

    Patient-reported conception plan will be evaluated by interview to assess whether pregnancy was achieved or it was opted to forgo the plan.

    Time frame: Six months after randomization

  2. FertiQoL

    Change in Quality of Life as Measured by the Fertility Quality of Life (FertiQoL) Questionnaire. The FertiQoL is a validated instrument that measures quality of life in individuals experiencing fertility problems. Scores range from 0 to 100, where higher scores indicate better quality of life.

    Time frame: Six months after randomization

  3. Time to regulation decision

    Time in days between the referral and final decision for the referral

    Time frame: Six months after randomization

  4. Time for in-person consulting

    Time in days between the referral and in-person consult.

    Time frame: Six months after randomization

07

Study locations

1 site
  • Hospital de Clínicas de Porto Alegre (HCPA)
    Porto Alegre, Rio Grande do Sul 90035-903, Brazil
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06979063
Lead sponsor
Hospital de Clinicas de Porto Alegre
Collaborators
Telessaúde RS
Responsible party
Michele Zschornack Strelow (Principal Investigator, Hospital de Clinicas de Porto Alegre) — Principal investigator
First posted
May 18, 2025
Start date
Jun 2025 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
May 18, 2025

Study contacts

Michele Strelow Moreira
Contact
mstrelowmoreira@gmail.com
+5551992607430
Helena von Eye Corleta
Contact
hcorleta@hcpa.edu.br
51999862749

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion